Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 4—April 2008

CME ACTIVITY

β-Herpesviruses in Febrile Children with Cancer

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify common infections associated with β-herpesviruses
  • Specify β-herpesviruses isolated from children in the current study
  • Describe clinical characteristics of β-herpesvirus infections in the current study
  • List factors associated with higher rates of infection with human herpesvirus in the current study

Editor

D. Peter Drotman, MD, Editor-in-Chief, Emerging Infectious Diseases. Disclosure: D. Peter Drotman, MD, has disclosed no relevant financial relationships.

CME AUTHOR

Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.

Authors

Stephanie Yee-Guardino, DO, Section of Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio. Disclosure: Stephanie Yee-Guardino, DO, has disclosed no relevant financial relationships.
Kate Gowans, MD, Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospital, Cleveland, Ohio. Disclosure: Kate Gowans, MD, has disclosed no relevant financial relationships.
Belinda Yen-Lieberman, PhD, Laboratory Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Belinda Yen-Lieberman, PhD, has disclosed that she has received reagents at no charge from ARTUS Diagnostics.
Pamela Berk, BS, Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Pamela Berk, BS, has disclosed no relevant financial relationships.
Debra Kohn, BS, MT, Laboratory Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Debra Kohn, BS, MT, has disclosed no relevant financial relationships.
Fu-Zhang Wang, PhD, Department of Molecular Genetics, Lerner Research, Institute Cleveland Clinic, Cleveland, Ohio. Disclosure: Fu-Zhang Wang, PhD, has disclosed no relevant financial relationships.
Lara Danziger-Isakov, MD, MPH, Section of Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio; Departments of Infectious Diseases, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Lara Danziger-Isakov, MD, MPH, has disclosed no relevant financial relationships.
Camille Sabella, MD, Section of Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio; Departments of Infectious Diseases, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Camille Sabella, MD, has disclosed that she has received grants from Merck, Inc. and Sanofi Pasteur.
Sarah Worley, MS, Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Sarah Worley, MS, has disclosed no relevant financial relationships.
Philip E. Pellett, PhD, Departments of Infectious Diseases, Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Philip E. Pellett, PhD, has disclosed that he has received royalties from Chemicon International.
Johanna Goldfarb, MD, Section of Pediatric Infectious Diseases, Children's Hospital, Cleveland, Ohio; Departments of Infectious Diseases, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Disclosure: Johanna Goldfarb, MD, has disclosed no relevant financial relationships.

Article Navigation

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

TOP